Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M28.9Revenue (TTM) $M--Net Margin (%)--Altman Z-Score-7.4
Enterprise Value $M-2.2EPS (TTM) $-0.2Operating Margin %--Piotroski F-Score3
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yY
Price/Book1.010-y EBITDA Growth Rate %-19.4Quick Ratio11.3Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %-33.5Current Ratio11.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-40.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-43.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M64.2ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with BIOD

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIODDavid Swensen 2010-12-31 Sold Out $6.44 - $19.08
($10.17)
$ 0.45-96%Sold Out0
BIODDavid Swensen 2009-12-31 Buy 11.73%$14.16 - $21.04
($17.18)
$ 0.45-97%New holding225,850
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIOD is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


BIOD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Pereira Brian JGDirector 2013-12-20Sell4,734$2.26-80.09view
LIEBERMAN IRADirector 2013-12-20Buy10,800$2.29-80.35view
Bavier Paul SGeneral Counsel/Corp. Sec. 2012-12-07Sell12,256$2.8-83.93view
Bavier Paul SGeneral Counsel/Corp. Sec. 2012-11-02Sell3,500$2.81-83.99view
Krasner Alan SethChief Medical Officer 2012-11-02Sell3,500$2.81-83.99view
DESOUZA ERROL BCEO 2012-09-20Buy10,000$3.34-86.53view
Bavier Paul SGeneral Counsel/Corp. Sec. 2012-03-13Sell2,096$2.36-80.93view
Pereira Brian JGDirector 2011-12-16Sell3,750$2.6-82.69view
Steiner SolomonDirector 2011-09-26Sell32,695$4.36-89.68view
Steiner SolomonDirector 2011-09-21Sell79,129$4.72-90.47view

Press Releases about BIOD :

Quarterly/Annual Reports about BIOD:

News about BIOD:

Articles On GuruFocus.com
No related article found.

More From Other Websites
BIODEL INC Financials Aug 19 2016
BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Aug 12 2016
BIODEL INC Files SEC form 10-Q, Quarterly Report Aug 11 2016
Biodel Reports Third Quarter Fiscal Year 2016 Financial Results Aug 11 2016
BIODEL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and... Jul 13 2016
Research Report Initiated on Select Drug Manufacturers Equities Jun 27 2016
Biodel Reports Second Quarter Fiscal Year 2016 Financial Results May 31 2016
The Zacks Analyst Blog Highlights: XenoPort, Biodel and AbbVie May 26 2016
BIODEL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and... May 26 2016
Biotech Stock Roundup: XenoPort Soars on Acquisition Deal, AbbVie Crohn's Disease Drug Fares Well May 25 2016
BIODEL INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 25 2016
Biodel/Albireo Limited to Combine; Focus on Liver Diseases May 25 2016
Biodel Inc. and Albireo Limited Agree to Combine May 24 2016
BIODEL INC Files SEC form 10-Q, Quarterly Report May 10 2016
BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... May 09 2016
Biodel Reports Second Quarter Fiscal Year 2016 Financial Results May 09 2016
BIODEL INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and... Apr 01 2016
BIODEL INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or... Mar 24 2016
BIODEL INC Files SEC form 8-K, Change in Directors or Principal Officers Mar 02 2016
BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Feb 16 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)